1-Substituted-4-[3-(1,2,3,4-tetrahydro-5- or 7-methoxynaphthalen-1-yl)propyl]piperazines: influence of the N -1 piperazine substituent on 5-HT 1A receptor affinity and selectivity versus D 2 and α 1 receptors. Part 6

This publication has 34 references indexed in Scilit:

• 1-Aryl-4-[(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)alkyl]piperazines and Their Analogues: Influence of the Stereochemistry of the Tetrahydronaphthalen-1-yl Nucleus on 5-HT_1A Receptor Affinity and Selectivity versus α₁ and D₂ Receptors. 5
  Journal of Medicinal Chemistry, 1999
• N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover
  Brain Research Protocols, 1997
• Selective decline of 5-HT1A receptor binding sites in rat cortex, hippocampus and cholinergic basal forebrain nuclei during aging
  Journal of Chemical Neuroanatomy, 1997
• Pyramidal Neurone Modulation: A Therapeutic Target for Alzheimer's Disease
  Neurodegeneration, 1996
• Recent developments in anxiety, stress, and depression
  Pharmacology Biochemistry and Behavior, 1996
• 5-HT1A receptor agonists: recent developments and controversial issues
  Psychopharmacology, 1995
• Evidence for specific interactions between 5-HT1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat
  Pharmacology Biochemistry and Behavior, 1994
• 5‐Hydroxytryptamine_1AReceptor Agonists in Animal Models of Depression and Anxiety
  Basic & Clinical Pharmacology & Toxicology, 1992
• Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
• 5-HT1A receptor responsivity in anxiety disorders and depression
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1991